Natural Products in Clinical Trials/ (Record no. 157658)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01544nam a22001817a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220322122355.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220322b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-9811425752 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | LC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Relator code | Atta -ur-Rahman |
| Personal name | (Editor) |
| 245 ## - TITLE STATEMENT | |
| Title | Natural Products in Clinical Trials/ |
| Statement of responsibility, etc | Atta-ur- Rahman, Shazia Anjum and Hesham El-Seedi (Editors) |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Sharja: |
| Name of publisher, distributor, etc | Bentham Science Publishers, |
| Date of publication, distribution, etc | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 356 pages |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Volume number/sequential designation | Volume: 2 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives. This book series presents reviews of exciting new bioactive natural products that have huge potential as drugs. Each volume presents comprehensive chapters contributed by eminent scientists. The volumes focus on drug candidates which are in the later stages of drug development and are being evaluated in clinical trials. The series, therefore, highlights the importance of natural products in our lives.<br/><br/>The second volume covers the following topics:<br/><br/>- A review of recent patents and natural products in clinical trials to treat schistosomiasis<br/><br/>- Natural products: the new intervention regimen for metabolic disorders<br/><br/>- Fluorine-containing drugs and drug candidates derived from natural products<br/><br/>- Natural products for the management of cardiovascular diseases<br/><br/>- Implication of natural compounds for the prevention of ocular diseases |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Book |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | 22/03/2022 | RS160.N38_2020 | P 2970 | 22/03/2022 | 22/03/2022 | Book |